Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality
Authors:
Open Access
- 1 September 2017
- journal article
- case report
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (9) , 1582-1587
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Targeted Pathologic Evaluation of Bone Marrow Donors Identifies Previously Undiagnosed Marrow AbnormalitiesTransplantation and Cellular Therapy, 2013
- Management of autoimmune diseases after haematopoietic stem cell transplantationBritish Journal of Haematology, 2012
- Hematopoietic-Cell Transplantation at 50New England Journal of Medicine, 2007
- Transmission of donor illness by stem cell transplantation: should screening be different in older donors?Bone Marrow Transplantation, 2004
- Hematopoietic stem cell transplantation for hematological malignancies in EuropeLeukemia, 2003
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseasesBlood, 2003
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeBone Marrow Transplantation, 2002
- Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimenBlood, 2002
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsBlood, 2001
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998